| Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
| Adverse effects | |||||
|
RCT |
People with psoriasis |
Adverse effects
with ciclosporin with etretinate |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.